Comparison · NCT02694185-deaths
Experimental Group vs Control Group: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Experimental Group vs Control Group: deaths from any cause. Trial comparisons, record NCT02694185-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02694185-deaths
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0483 | 0.0324 | 0.0715 | wilson | |
| Risk in group 2 | 0.0436 | 0.0382 | 0.0498 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00471 | -0.0123 | 0.0285 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.11 | 0.728 | 1.69 | log | |
| Odds ratio, group 1 over group 2 | 1.11 | 0.716 | 1.73 | log | |
| Number needed to harm, for one more death from any cause on Experimental Group than on Control Group | 212 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Experimental Group | This group will undergo the intervention as described in the protocol~Caplan IVR: This intervention will consist of: proactive real-time adherence monitoring of patients and targeting of individuals only when they have exhibited non-adherence behavior (i.e., if patients have not refilled their medication more than 4 or 7 days after it was due to be refilled). The intervention will employ a tailored, escalating-intensity approach which begins with some combination of personalized short messaging service (SMS) text messages and interactive voice response (IVR) telephone technology, depending on patient preference. Patients failing SMS and then IVR by not refilling their medication (or declining SMS and failing IVR) escalate to a trained research interventionalist (typically, a clinical pharmacist). The interventionalist will contact the patient and address adherence barriers based on the dimensions outlined by the World Health Organization (WHO) that are specific to each patient. | 23 | 476 | EG000 |
| Group 2 | Control Group | This group will not receive the intervention, they will receive usual care | 209 | 4,793 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, all-cause mortality
- Time frame
Source ClinicalTrials.gov
Trial
- Title
- Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
- NCT number
- NCT02694185
- Phases
- NA
- Conditions
- Myocardial Ischemia, Rheumatic Diseases
- Interventions
- Caplan IVR
- Lead sponsor
- VA Office of Research and Development
- Results first posted
- 2021-06-25
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02694185?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02694185-deaths